Achilles Therapeutics (Achilles Therapeutics) Other Gross PPE : $23.35 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Other Gross PPE?

Achilles Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was $23.35 Mil.

Achilles Therapeutics's quarterly Other Gross PPE declined from Sep. 2023 ($25.32 Mil) to Dec. 2023 ($23.74 Mil) and declined from Dec. 2023 ($23.74 Mil) to Mar. 2024 ($23.35 Mil).

Achilles Therapeutics's annual Other Gross PPE increased from Dec. 2021 ($25.57 Mil) to Dec. 2022 ($25.72 Mil) but then declined from Dec. 2022 ($25.72 Mil) to Dec. 2023 ($23.74 Mil).

Achilles Therapeutics Other Gross PPE Historical Data

The historical data trend for Achilles Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics Other Gross PPE Chart

Achilles Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

1.90

26.34

25.57

25.72

23.74

Achilles Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial													19.02	19.32	25.32	23.74	23.35

Achilles Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Achilles Therapeutics (Achilles Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.